KraneShares Emerging Markets Healthcare Index ETF
KMED
KMED was delisted on the 18th of October, 2023.
3 hedge funds and large institutions have $280K invested in KraneShares Emerging Markets Healthcare Index ETF in 2022 Q4 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 1 reducing their positions, and closing their positions.
25% more capital invested
Capital invested by funds: $224K → $280K (+$56.3K)
0% more funds holding
Funds holding: 3 → 3 (0)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$30.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$2.57K |
KMED Hedge Fund Activity: Q4 2022 in Review
3 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in KraneShares Emerging Markets Healthcare Index ETF (KMED) for Q4 2022, worth a combined $280K — up 25% from $224K a quarter earlier.
Fund positioning in KMED was balanced in Q4 2022: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 1 trimmed.
The largest buyer was Jane Street, adding an estimated $30.5K. The largest seller was UBS Group, cutting an estimated $2.57K.
- 3 institutional investors held KraneShares Emerging Markets Healthcare Index ETF (KMED) as of Q4 2022, unchanged from Q3 2022.
- Funds reported $280K of KraneShares Emerging Markets Healthcare Index ETF stock for Q4 2022, up 25% quarter-over-quarter.
- 0 funds opened new KraneShares Emerging Markets Healthcare Index ETF positions in Q4 2022 and 0 closed out.
- The largest KraneShares Emerging Markets Healthcare Index ETF buyer in Q4 2022 was Jane Street, an estimated $30.5K added.
- The largest KraneShares Emerging Markets Healthcare Index ETF seller in Q4 2022 was UBS Group, an estimated $2.57K sold.
Based on aggregated 13F filings for Q4 2022.